Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 17;71(10):e624-e632.
doi: 10.1093/cid/ciaa293.

Prevalence of Mycoplasma genitalium Infection, Antimicrobial Resistance Mutations, and Symptom Resolution Following Treatment of Urethritis

Laura H Bachmann  1 , Robert D Kirkcaldy  1 , William M Geisler  2 , Harold C Wiesenfeld  3 , Lisa E Manhart  4 , Stephanie N Taylor  5 , Arlene C Seña  6 , Candice J McNeil  7 , Lori Newman  8 , Noelle Myler  9 , Rachael Fuchs  9 , Katherine E Bowden  1 ; MAGNUM Laboratory Working Group
Collaborators, Affiliations

Prevalence of Mycoplasma genitalium Infection, Antimicrobial Resistance Mutations, and Symptom Resolution Following Treatment of Urethritis

Laura H Bachmann et al. Clin Infect Dis. .

Abstract

Background: Antimicrobial resistance in Mycoplasma genitalium (MG), a cause of urethritis, is a growing concern. Yet little is known about the geographic distribution of MG resistance in the United States or about its associated clinical outcomes. We evaluated the frequency of MG among men with urethritis, resistance mutations, and posttreatment symptom persistence.

Methods: We enrolled men presenting with urethritis symptoms to 6 US sexually transmitted disease (STD) clinics during June 2017-July 2018; men with urethritis were eligible for follow-up contact and, if they had persistent symptoms or MG, a chart review. Urethral specimens were tested for MG and other bacterial STDs. Mutations in 23S ribosomal ribonucleic acid (rRNA) loci (macrolide resistance-associated mutations [MRMs]) and in parC and gyrA (quinolone-associated mutations) were detected by targeted amplification/Sanger sequencing.

Results: Among 914 evaluable participants, 28.7% (95% confidence interval [CI], 23.8-33.6) had MG. Men with MG were more often Black (79.8% vs 66%, respectively), <30 years (72.9% vs 56.1%, respectively), and reported only female partners (83.7% vs 74.2%, respectively) than men without MG. Among MG-positive participants, 64.4% (95% CI, 58.2-70.3%) had MRM, 11.5% (95% CI, 7.9-16.0%) had parC mutations, and 0% had gyrA mutations. Among participants treated with azithromycin-based therapy at enrollment and who completed the follow-up survey, persistent symptoms were reported by 25.8% of MG-positive/MRM-positive men, 13% of MG-positive/MRM-negative men, and 17.2% of MG-negative men.

Conclusions: MG infection was common among men with urethritis; the MRM prevalence was high among men with MG. Persistent symptoms following treatment were frequent among men both with and without MG.

Keywords: Mycoplasma genitalium; persistence; resistance; urethritis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Participant flow diagram. Abbreviation: MB/GV, Gram or methylene blue/gentian violet.
See this image and copyright information in PMC

References

    1. Chambers LC, Morgan JL, Lowens MS, et al. . Cross-sectional study of urethral exposures at last sexual episode associated with non-gonococcal urethritis among STD clinic patients. Sex Transm Infect 2019; 95:212–8. - PMC - PubMed
    1. Ito S, Hanaoka N, Shimuta K, et al. . Male non-gonococcal urethritis: from microbiological etiologies to demographic and clinical features. Int J Urol 2016; 23:325–31. - PubMed
    1. Manhart LE, Gillespie CW, Lowens MS, et al. . Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial. Clin Infect Dis 2013; 56:934–42. - PMC - PubMed
    1. Schwebke JR, Rompalo A, Taylor S, et al. . Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens–a randomized clinical trial. Clin Infect Dis 2011; 52:163–70. - PMC - PubMed
    1. Taylor-Robinson D, Jensen JS. Mycoplasma genitalium: from chrysalis to multicolored butterfly. Clin Microbiol Rev 2011; 24:498–514. - PMC - PubMed

Publication types